StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
016920.KQ$824.00-3.06%
Fair $824.00+0.0%

016920.KQ

CAS Corporation

Unknown / UnknownKOSDAQ

$824.00

-26.00 (-3.06%)

Fairly Valued+0.0%Fair Value $824.00Fund rank 22/100 · Data gapFallback financials|
SA 14/F
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $3.8B · quality 33.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 7/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

14/100

F

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -2.4%, below the 5% threshold
Thesis & Journal · 016920.KQLocal privado en este navegador · CAS Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$20.2B

P/E

N/A

•

EV/EBITDA

13.6x

↑

ROE

-2.4%

↓

Gross Margin

30.4%

↑

Debt/Equity

0.85

↑
52-Week Range$824
$807$1647

TradingView lightweight chart

016920.KQ price, volumen y niveles de valoración

Último $824.00Periodo -75.1%
Fair value: $824.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-1.5%

FCF CAGR

—

FCF margin

2.3%

FCF / Net income

-2.27x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $161.07B · net income $-1.66B · FCF $3.77B

2022-FY → 2025-FY

Gross margin

30.4%+2.1% pts

Operating margin

1.3%-1.9% pts

Net margin

-1.0%-2.7% pts

FCF margin

2.3%+2.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$161.07B$161.07B$156.00B$156.03B$168.36B
Net Income$-1.66B$-1.66B$1.31B$1.73B$2.74B
EBITDA$5.38B$5.38B$8.84B$9.48B$11.41B
EPS-67.00-67.0052.0055.00112.00
Gross Margin30.4%30.4%30.2%29.7%28.3%
Operating Margin1.3%1.3%2.3%3.2%3.2%
Net Margin-1.0%-1.0%0.8%1.1%1.6%
Balance Sheet
Debt/Equity0.850.850.850.871.11
Cash Flow
Free Cash Flow$3.77B$3.77B$-2.98B$4.29B$-49.8M
Returns
ROE-2.4%-2.4%1.9%2.7%4.5%
Valuation
P/E——44.7127.4215.31
EV/EBITDA13.6513.6512.739.568.08
P/B0.300.300.840.610.66
Growth & Yield
Revenue Growth3.2%3.2%-0.0%-7.3%—
EPS Growth-228.8%-228.8%-5.5%-50.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -48.6%

Total return

-48.6%

Start / end P/E

n/dx → n/dx

EPS bridge

52.00 → -67.00

Residual

-48.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-48.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.